Altus Pharmaceuticals

Biotech & Life Sciences · Independence, United States · Founded 1996 · IPO 2006

Altus Technologies Corporation provides consulting and implementation services for IT. Our services include: • Data center consolidation and relocation services • IT mergers, migration planning and execution • Data center strategy • Enterprise IT Infrastructure roll-outs and refreshes • Technology refresh planning and implementations • Technical and Infrastructure project management (PMI Certified) • Physical and logical security (physical access systems, firewalls, network video systems) • Enterprise IT Architecture Our clients include many large firms in banking, insurance, healthcare, retail and manufacturing.

Valuation $1–2.5B

Revenue $100–500M

EBITDA $87M

Headcount <100

Total funding $100–500M

Power Law Unicorn$1–10B valuation tier Thoroughbred$100M+ revenue

Investors

3 investors on Altus Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage

Cystic Fibrosis Foundation

Series A 1 investor entered at this stage

U.S. Venture Partners

Series B+ 1 investor entered at this stage

Warburg Pincus

Global footprint

Where Altus Pharmaceuticals has talent and traffic

Workforce by country

2 countries with
team presence

🇺🇸 United States85.7%

🇮🇳 India14.3%

2 countries shown

Web traffic by country

120 monthly visits
across markets

🇺🇸 United States83.3%

Top 1 markets shown

Talent graph

The shape of Altus Pharmaceuticals's talent

Dealroom maps Altus Pharmaceuticals's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

11 team members profilednamed & role-tagged by Dealroom

12 employeestotal headcount

4 executives & foundersidentified by name

DimensionScore

AI Talent

Engineering

Product

Go-to-market

Leadership

Research

Book a demo to unlock Altus Pharmaceuticals's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$2M patent portfolio · 1 active families

Estimated portfolio value

$2M

0.17% of market cap · 49.9× smaller than top peer Dicerna Pharmaceuticals ($100M)

1 active patent families

Where Altus Pharmaceuticals innovates BiochemistryChemical compositionCleaning agentCleansing AgentsCrystal

Where Altus Pharmaceuticals concentrates vs peers

Each axis is a top-10 topic across Altus Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Altus Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Altus Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Altus Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles